Cite
Mitotropic triphenylphosphonium doxorubicin-loaded core-shell nanoparticles for cellular and mitochondrial sequential targeting of breast cancer.
MLA
Arafa, Kholoud K., et al. “Mitotropic Triphenylphosphonium Doxorubicin-Loaded Core-Shell Nanoparticles for Cellular and Mitochondrial Sequential Targeting of Breast Cancer.” International Journal of Pharmaceutics, vol. 606, Sept. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2021.120936.
APA
Arafa, K. K., Smyth, H. D. C., & El-Sherbiny, I. M. (2021). Mitotropic triphenylphosphonium doxorubicin-loaded core-shell nanoparticles for cellular and mitochondrial sequential targeting of breast cancer. International Journal of Pharmaceutics, 606, N.PAG. https://doi.org/10.1016/j.ijpharm.2021.120936
Chicago
Arafa, Kholoud K., Hugh D.C. Smyth, and Ibrahim M. El-Sherbiny. 2021. “Mitotropic Triphenylphosphonium Doxorubicin-Loaded Core-Shell Nanoparticles for Cellular and Mitochondrial Sequential Targeting of Breast Cancer.” International Journal of Pharmaceutics 606 (September): N.PAG. doi:10.1016/j.ijpharm.2021.120936.